i. The pharmaceutical industry in India is currently valued at $50 bn.

ii. The Indian pharmaceutical industry is a large and diverse sector that plays a significant role in the country's economy. It is the third largest in the world in terms of volume and is expected to grow further in the coming years.

iii. India is a major exporter of Pharmaceuticals, with over 200+ countries served by Indian pharma exports. India supplies over 50% of Africa’s requirement for generics, ~40% of generic demand in the US, and ~25% of all medicine in the UK.

iv. Government incentives including an outlay of INR 21940 for PLI 1.0 and PLI 2.0.

v. Infrastructure development - India has the highest number of US-FDA-compliant plants outside the US.

vi. Strong drug manufacturing - Expertise in low-cost generic patented drugs as well as end-to-end manufacturing. In recent years, the Indian pharmaceutical industry has also made significant investments in research and development, as well as in the production of innovative drugs. vii. In the past 1-1.5 years, Indian Pharma Sector as a whole has seen major downturns in terms of revenue and profitability due to a decrease in demand and an increase in input prices. However, given that this is a short-term phenomenon, we expect the Indian Pharma companies to bounce back in terms of revenue and profitability with improving demand from major parts of the world.